Triplex International Biosciences (China) Co., LTD

Founded in 2 0 0 4, Triplex International Biosciences (China) Co., Ltd (hereinafter refer to TIB) has become a high-tech biomedical enterprise integrating the research and development, production and sales of molecular diagnostic and supporting instruments, as well as providing high-end medical diagnostic services.

TIB is also a national high-tech enterprise, the executive director unit of Chinese Union of Translational Medicine and Biotechnology Alliance, the president unit of Fujian Provincial In vitro Diagnostic Reagent Industrial Technology Strategic Alliance, and an outstanding high-tech enterprise in Xiamen.

TIB has been committed to building its own high-end medical diagnosis research and development highland. It has set up independent research centers in Beijing, Xiamen and Fuzhou cities on the basis of the research platforms such as "The State-Local Joint Engineering Lab for Molecular Diagnosis", "The Fujian Provincial Engineering Lab for Molecular Diagnosis", "Fujian-Taiwan Medical Instrument Technology Cooperation Base", etc. TIB has also cooperatively established joint R&D centers with famous scientific research institutes in China and abroad, such as "The TIB-Peking University Laboratory of Molecular Pathology¬ with Peking University Medical Center, "The School of Life Sciences-TIB Biomedical Diagnostic Research and Development Center¬ with Xiamen University Biology Department, "The Fujian Provincial Key Laboratory of Joint Hepatobiliary Technology Innovation "with Shanghai Oriental Hepatic Hospital of Second Military Medical University headed by academician Wu Mengchao and Meng Chao Hepatobiliary Hospital of Fujian Medical University. In addition, TIB has carried out extensive R&D cooperation with famous universities and professional R&D institutions such as Second Military Medical University, Taipei University of Science and Technology, Yale University and Columbia University. Through the extensive Industry-university-research cooperation, TIB has built a leading high-end medical diagnostic R&D platform in line with international standards, and has accelerated the pace of internationalization.